Skip to main content
. 2025 Aug 25;39(10):1037–1052. doi: 10.1007/s12149-025-02092-x

Table 4.

Prognostic markers in cardiac amyloidosis imaging

Modality Prognostic markers
Echocardiography

Apical sparing pattern: suggests better preserved function

Reduced RV free wall strain: predicts worse outcomes

Myocardial work indices and GLS dispersion: associated with adverse prognosis

SPECT/CT

High myocardial SUVmax or retention index: associated with worse outcomes

RV uptake: linked to greater disease burden and mortality

Correlates with ECV and LV mass on CMR

CMR

Elevated ECV: associated with reduced survival

Prolonged T2 relaxation time: independent predictor of mortality

High native T1 values: associated with poor outcome

Reduced GLS and LA strain: predictive of MACE

ATTR, transthyretin amyloidosis; AL, light-chain amyloidosis; SPECT/CT, single-photon emission computed tomography/computed tomography; CMR, cardiovascular magnetic resonance; ECV, extracellular volume; T1/T2, MRI relaxation times; SUV, standardized uptake value; SUVmax, maximum standardized uptake value; GLS, global longitudinal strain; LA, left atrial; MACE, major adverse cardiovascular events; LV, left ventricle; RV, right ventricle